2026-06-14T05:05:06Zhttps://repisalud.isciii.es/rest/oai/requestoai:repisalud.isciii.es:20.500.12105/48112024-11-14T21:04:29Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19609
Repisalud
author
Álvaro-Meca, Alejandro
author
Jimenez-Sousa, Maria Angeles
author
Boyer, Alexandre
author
Medrano, José
author
Reulen, Holger
author
Kneib, Thomas
author
Resino, Salvador
funder
Instituto de Salud Carlos III
2017-09-04T16:28:13Z
2017-09-04T16:28:13Z
2016-03-12
BMC Infect Dis. 2016; 16: 122
10.1186/s12879-016-1448-8
1471-2334
BMC Infectious Diseases
26979964
http://hdl.handle.net/20.500.12105/4811
BACKGROUND:
Cirrhosis and severe sepsis are factors associated with increased mortality in intensive care unit (ICU), but chronic hepatitis C (CHC) has been less studied in ICU. The aim of this study was to analyze the impact of CHC on the mortality of cirrhotic patients admitted to ICU according to severe sepsis and decompensated cirrhosis.
METHODS:
We carried out a retrospective study based on CHC-cirrhotic patients (CHC-group) admitted to ICU (n = 1138) and recorded in the Spanish Minimum Basic Data Set (2005-2010). A control-group (randomly selected cirrhotic patients without HIV, HBV, or HCV infections) was also included (n = 4127). The primary outcome variable was ICU mortality. The cumulative mortality rate on days 7, 30, and 90 in patients admitted to the ICUs was calculated by dividing the number of deaths by the number of patients admitted to the ICU. The adjusted hazard ratio (aHR) for death in the ICU was estimated through a semi-parametric Bayesian model of competing risk.
RESULTS:
The CHC-group had a higher cumulative incidence of severe sepsis than the control-group in compensated cirrhosis (37.4 vs. 31.1%; p = 0.024), but no differences between the CHC-group and the control-group in decompensated cirrhosis were found. Moreover, a higher cumulative incidence of severe sepsis was associated with decompensated cirrhosis compared to compensated cirrhosis in the control-group (40.1 vs. 31.1%; p < 0.001) whereas this was not observed in the CHC group (38.1 vs. 37.4%; p = 0.872). The CHC-group had higher cumulative mortality than the control-group by days 7 (47 vs. 41.3%; p < 0.001), 30 (78.5 vs. 73.5%; p < 0.001), and 90 (96.3 vs. 95.9%; p < 0.001). In a competitive risk model, the CHC-group had a higher risk of dying if the ICU course was complicated by severe sepsis (adjusted hazard ratio (aHR) = 1.19; p = 0.003), but no significant values in patients with absence of severe sepsis were found (aHR = 1.09; p= 0.068). When patients were stratified by cirrhosis stage and severe sepsis, CHC patients with compensated cirrhosis had the higher risk of death if they had severe sepsis (aHR = 1.35; p = 0.002). Moreover, the survival was low in patients with decompensated cirrhosis and severe sepsis but we did not find significant differences between CHC-group and control-group.
CONCLUSIONS:
CHC was associated with an increased risk of death in cirrhotic patients admitted to ICUs, particularly in patients with compensated cirrhosis and severe sepsis.
eng
Critical care
Survival
Chronic hepatitis C
Severe sepsis, HCV
Impact of chronic hepatitis C on mortality in cirrhotic patients admitted to intensive-care unit
journal article
URL
https://repisalud.isciii.es/bitstreams/6f71163b-1c7e-4217-8035-795f3383fc22/download
File
MD5
81aeeaf6be56cd2c91b9198a67cce457
981064
application/pdf
ImpactOfChronicHepatitis_2016.pdf
URL
https://repisalud.isciii.es/bitstreams/2c1c82b1-a69c-4fea-a959-d58719420d53/download
File
MD5
7168ebaa5724edc16d18799d22108a1b
42006
text/plain
12879_2016_Article_1448.pdf.txt
URL
https://repisalud.isciii.es/bitstreams/247ec120-e802-42fe-8389-e67f71df5116/download
File
MD5
7168ebaa5724edc16d18799d22108a1b
42006
text/plain
ImpactOfChronicHepatitis_2016.pdf.txt